Crossmark

In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020–2021: a multicenter study

Crossref DOI link: https://doi.org/10.1007/s10096-023-04616-7

Published Online: 2023-05-03

Published Print: 2023-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Galani, Irene https://orcid.org/0000-0001-6455-9848
Papoutsaki, Vassiliki

Karaiskos, Ilias https://orcid.org/0000-0002-2226-0239
Moustakas, Nikolaos

Galani, Lamprini

Maraki, Sofia https://orcid.org/0000-0003-0945-1732
Mavromanolaki, Viktoria Eirini

Legga, Olga

Fountoulis, Kimon

Platsouka, Evangelia D.

Giannopoulou, Panagiota

Papadogeorgaki, Helen

Damala, Maria

Chinou, Efrosini

Pasxali, Aggeliki

Deliolanis, Ioannis

Vagiakou, Helen

Petinaki, Efthymia

Chli, Anastasia

Vagdatli, Eleni

Kazila, Polyzo

Papaioannou, Vassiliki

Kontopoulou, Konstantina

Ferke, Atalia Noemi

Moraitou, Eleni

Antoniadou, Anastasia https://orcid.org/0000-0003-0991-9198
Giamarellou, Helen https://orcid.org/0000-0002-7387-5065
Funding

Funding for this research was provided by:

University of Athens
License Information

Text and Data Mining valid from 2023-05-03

Version of Record valid from 2023-05-03
More Information

Article History

Received: 3 January 2023

Accepted: 26 April 2023

First Online: 3 May 2023

Declarations

:

: None to declare.

Document is current

Any future updates will be listed below